Login / Signup

Carfilzomib, lenalidomide, and dexamethasone in patients with relapsed multiple myeloma categorised by age: secondary analysis from the phase 3 ASPIRE study.

Meletios A DimopoulosA Keith StewartTamás MassziIvan ŠpičkaAlbert OriolRoman HájekLaura RosiñolDavid SiegelGeorgi G MihaylovVesselina Goranova-MarinovaRajnics PeterAleksandr SuvorovRuben NiesvizkyAndrzej JakubowiakJesus San-MiguelHeinz LudwigAntonio PalumboMihaela ObrejaSanjay AggarwalPhilippe Moreau
Published in: British journal of haematology (2017)
clinicaltrials.gov identifier: NCT01080391.
Keyphrases
  • multiple myeloma
  • low dose
  • high dose
  • acute myeloid leukemia
  • hodgkin lymphoma
  • data analysis